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Abstract
RalA is a membrane-associated small GTPase that regulates vesicle trafficking. Here we identify a specific interaction
between RalA and ERp57, an oxidoreductase and signalling protein. ERp57 bound specifically to the GDP-bound form of
RalA, but not the GTP-bound form, and inhibited the dissociation of GDP from RalA in vitro. These activities were inhibited
by reducing agents, but no disulphide bonds were detected between RalA and ERp57. Mutation of all four of ERp57’s active
site cysteine residues blocked sensitivity to reducing agents, suggesting that redox-dependent conformational changes in
ERp57 affect binding to RalA. Mutations in the switch II region of the GTPase domain of RalA specifically reduced or
abolished binding to ERp57, but did not block GTP-specific binding to known RalA effectors, the exocyst and RalBP1.
Oxidative treatment of A431 cells with H2O2 inhibited cellular RalA activity, and the effect was exacerbated by expression of
recombinant ERp57. The oxidative treatment significantly increased the amount of RalA localised to the cytosol. These
findings suggest that ERp57 regulates RalA signalling by acting as a redox-sensitive guanine-nucleotide dissociation
inhibitor (RalGDI).
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Introduction
RalA belongs to the Ras family of small GTPases [1]. These are
generally membrane-associated signalling proteins that cycle
between an active GTP-bound state, which binds signalling
molecules called effectors to propagate signalling, and an inactive
GDP-bound state that does not bind effectors [2]. The GTPase
cycle is tightly controlled by three main types of regulatory
proteins: Guanine-nucleotide exchange factors (GEFs) that pro-
mote the dissociation of bound GDP to allow replacement with
GTP, GTPase activating proteins (GAPs) that generate the
inactive GDP-bound form, and Guanine-nucleotide dissociation
inhibitors (GDIs) that bind and stabilise the GDP-bound form and
block membrane binding to prevent activity of the small GTPase
[3,4].
GDIs effectively extract small GTPases from their active
location on the surface of membranes by binding to the GTPase
domain and by enveloping the C-terminal lipid adduct of the small
GTPase, in what is thought to be a two-step process [5–8]. A
cytosolic GDI-GTPase complex may then relocate to another
intracellular site before disassociating, possibly with the aid of
a release factor [9–11], allowing reactivation of the small GTPase
via GEF activity [6,12]. Whereas many specific GEF and GAP
proteins exist for small GTPases, GDIs have only been described
in detail for the Rab and Rho small GTPase families [4].
RalA is found on a variety of cellular membranes [13]. The
closely related paralog RalB has several common activities with
RalA, but the two proteins differ somewhat in sub-cellular and
tissue distribution and cellular function [14,15]. Ral proteins are
involved in receptor-mediated endocytosis, through a Ral effector
protein, RalBP1, and through Ral-stimulated phospholipase D
(PLD) activity [13,16]. Ral also controls exocytosis via an effector
complex called the exocyst [17–19]. The exocyst is an eight-
protein assembly involved in tethering secretory vesicles to specific
sites on the plasma membrane where exocytosis is to occur [20].
The central position of the Ral proteins in vesicle trafficking events
makes them important contributors to many cellular activities
including polarized exocytosis, filopodia formation, cell migration,
cytokinesis, autophagy, neurite branching, synaptic vesicle regu-
lation and mitochondrial fission [1,13,15,21]. Activated Ral is also
a mediator of tumorigenesis [16].
Studies of the signalling pathways upstream of Ral have almost
exclusively concerned its activators. Several GEFs have been
described and the most characterised is RalGDS, a Ras effector
protein [22]. There have also been a number of Ras-independent
RalGEFs described [23,24], and Ral can also be activated by
intracellular Ca2+ [13]. In contrast, inhibitory regulators of Ral
signalling are poorly understood. The existence of possibly two
RalGAP proteins has been reported, but neither has been
identified completely [25,26]. Here, we report the identification
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of the multifunctional protein, ERp57, as a redox-sensitive specific
binding protein of RalA that shows the hallmarks of a RalGDI.
Materials and Methods
Ethics Statement
The isolation of organs from animals was done with approval
from the Animal Care and Ethics Committee for the Children’s
Medical Research Institute and The Children’s Hospital West-
mead (approval number C116), Sydney, Australia.
Antibodies and other Materials
Anti-RalA monoclonal and anti-RalB polyclonal antibodies
were obtained from BD Transduction laboratories. Anti-6xHis tag
polyclonal antibody was obtained from Santa Cruz Biotechnology,
Inc. Anti-ERp57 polyclonal antibody was obtained from Stress-
Gen Biotechnologies (Figure 1), and for subsequent experiments
rabbit anti-ERp57 sera were generated using peptide sequences
from ERp57. Anti-GFP polyclonal and monoclonal antibodies
were obtained from BD Biosciences Clontech. Polyclonal anti-PDI
antiserum was a kind gift from Philip Hogg (University of New
South Wales, Australia). All other antibodies were previously
described [19]. N-acetylcysteine (NAC) and hydrogen peroxide
solution were from Sigma Aldrich Pty Ltd.
Recombinant RalA, ERp57 and Mutant Proteins
A fragment of human ERp57 cDNA, without the region
encoding the N-terminal signal peptide (amino acids 1–23), cloned
in a pET9 vector was provided by David Thomas (Montreal,
Canada). pGEX-2T-RalA, containing simian RalA cDNA, was
provided by Yoshito Kaziro (Yokohama, Japan). The RalA and
ERp57 coding regions were subcloned into pDONR201 (Invitro-
gen Corp.) and subjected to site-directed mutagenesis when
necessary (QuikChange, Stratagene). Clones were verified by
DNA sequencing. The ORFs were further sub-cloned by
recombination into pDEST15 (bacterial N-terminal GST-tag),
pDEST17 (bacterial N-terminal 6xHis-tag) and pcDNA-DEST53
(mammalian N-terminal GFP-tag) expression vectors (Invitrogen).
Expression of 6xHis-ERp57 in Escherichia coli and purification
using Ni-NTA resin (Qiagen) were carried out according to the
manufacturer’s protocol. Large quantities of plasmid DNA for
transfection of mammalian cells were prepared using the Wizard
Plus Maxipreps DNA purification system (Promega). GST-RalA
beads were prepared as previously described [19]. When
necessary, GST-RalA was eluted from GSH agarose with
50 mM Tris pH 8.0, 2.5 mM MgCl2, 20 mM reduced GSH,
followed by dialysis into 20 mM Tris pH 7.4, 150 mM NaCl,
2.5 mM MgCl2.
Pull-down Experiments, SDS-PAGE, Western Blotting, In-
gel Digestion and MALDI-TOF MS
These were performed as described previously [19]. Densitom-
etry was performed using ImageQuant v5.2 (Molecular Dynamics).
Internal Edman Protein Sequencing
Bands of interest were excised from Coomassie Blue-stained
polyacrylamide gels. Edman degradation of tryptic peptides was
carried out by Newcastle Protein (University of Newcastle,
Australia).
GDI Activity Assays
The method was based on those previously described [27,28].
For each condition, 4 mM GST-RalA (in 20 mM Tris pH 7.4,
150 mM NaCl, 2.5 mM MgCl2) was loaded with 1 mM [3H]-
GDP in 10 ml of 20 mM Tris pH 7.4, 50 mM NaCl, 1% Triton
X-100, 7.5 mM EDTA, 20 mg/ml leupeptin, 2 mM PMSF, 2x
Complete protease inhibitor cocktail (Roche) at 37uC for 20
minutes. 1 M MgCl2 was then added to a final concentration of
10 mM, and the tubes were placed on ice for 5 minutes or until
needed. The reaction was started by adding an equal volume of
GDI assay buffer (20 mM Tris pH 7.4, 50 mM NaCl, 1%
Triton X-100, 40 mM EDTA, 2 mM GDP) with or without
recombinant 6xHis-ERp57. (The absence of Mg2+ allows the
dissociation of nucleotides from a small GTPase at a reasonable
rate.) The reaction was incubated for 10–60 minutes at 37uC.
20 ml aliquots were withdrawn from the bulk reaction at
intervals, and then diluted in 500 ml of ice-cold washing buffer
(20 mM Tris pH 7.4, 50 mM NaCl, 5 mM MgCl2) and stored
on ice. Samples were filtered through a 0.2 mm nitrocellulose
membrane under vacuum in an ice-cold manifold (Minifold II,
Schleicher and Schuell). The membrane was washed three times
with 0.5 ml of ice-cold washing buffer under vacuum and then
removed and stored in a tray on ice for 3–5 minutes in ice-cold
washing buffer. The membrane was blotted with filter paper, air
dried, and then cut into individual samples which were
incubated with 1 ml of 0.1 M HCl in scintillation vials for 20
minutes at room temperature. Scintillation fluid was added, the
vials were shaken well, and then the samples were counted for
tritium in a scintillation counter.
Cell Culture and Transfections
A431 human epidermal carcinoma cells [29] were cultured in
DMEM containing 10% foetal bovine serum (FBS). Cells were
transfected using FuGENE 6 reagent according to the manufac-
turer’s instructions (Roche Molecular Biochemicals), using OPTI-
MEM serum-free media (Gibco BRL). Cells were returned to the
incubator for 5 hours. The cells were washed with phosphate
buffered saline (PBS) and then incubated in DMEM medium with
or without 20 or 30 mM NAC.
Ral Activity Assay
The GST-RalBD plasmid construct (containing the Ral
binding domain of RalBP1, amino acids 401–522) was obtained
from Larry Feig (Boston, USA). GST-RalBD was overproduced
in E. coli as described for GST-RalA [19]. A431 cells were
seeded into 100 mm tissue culture dishes at ,26105 cells/dish,
and cultured to ,75–80% confluency overnight. The cells were
transfected, and if necessary, serum-starved overnight (as above)
and the specified treatments were applied. The cells were
washed twice with ice-cold PBS and then lysed on ice by the
addition of ice-cold lysis buffer (25 mM Tris pH 7.4, 150 mM
NaCl, 1% Triton X-100, 1 mM EGTA, 10 mM MgCl2, 20 mg/
ml leupeptin, 1 mM PMSF). Cells were scraped and vortexed
thoroughly. The lysates were centrifuged at 17,000 g for 10
minutes at 4uC. The supernatant was incubated with 10 mg
GST-RalBD protein beads for 30 minutes at 4uC in micro-spin
columns, with regular mixing, as previously described [30]. The
lysate was collected by centrifugation and the beads were
washed twice with lysis buffer (without protease inhibitors), then
once with 20 mM Tris pH 7.4 containing 2.5 mM MgCl2.
Protein was eluted with 30 ml SDS sample buffer, and analysed
by SDS-PAGE and Western blotting using the indicated
antibodies.
Subcellular Fractionation
A431 cells were seeded into 100 mm tissue culture dishes at
,26105 cells per dish, cultured to ,75–80% confluency, and
ERp57-RalA Interaction
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serum-starved (with or without NAC) overnight. The cells were
stimulated with H2O2, and if necessary, washed twice with ice-cold
PBS, and lysed on ice in 5 mM Tris pH 7.4 containing 5 mM
MgCl2, 20 mg/ml leupeptin and 1 mM PMSF. The cells were
scraped, and lysis was assisted by vigorous vortexing and passaging
through a 30-gauge needle. The cell lysates were centrifuged at
100,000 rpm for 40 minutes at 4uC in a TLA120 bench-top
ultracentrifuge rotor (Beckman). The supernatants (S100 cytosolic
fractions) were removed and analysed by SDS-PAGE and Western
blotting.
Immunoprecipitation
For each reaction, a 10 ml bed volume of protein G-agarose
beads (Roche) was coupled overnight to 1 ml anti-GFP polyclonal
antiserum in 400 ml PBS with rotation at 4uC. A431 cell lysate was
prepared as described for the Ral activity assays, and then a 20 ml
aliquot was withdrawn for a Western blotting control. The lysates
were then incubated with the anti-GFP antibody beads with
mixing for 1 hour at 4 &C. The lysate was then removed by
centrifugation using a Micro-spin column. The beads were washed
three times with ice-cold lysis buffer (without protease inhibitors),
and then twice with ice-cold 20 mM Tris pH 7.4, 2.5 mMMgCl2.
Figure 1. Isolation and identification of ERp57 as a GDP-RalA binding protein. (A) GST-RalA loaded with GDP or GTP was used as bait for
pull-down experiments from the indicated rat tissue extracts. Bound proteins were analysed by SDS-PAGE and Coomassie blue staining. A GDP-
dependent RalA binding protein, p58, is indicated. (B) MALDI-TOF mass spectrum of tryptic peptides derived from brain p58, showing peak identities,
matched against theoretical digests with a mass accuracy of 60.1 Da. (C) Western blotting of GST-RalA pull-down experiments from synaptosomes,
whole brain or testis extracts, probed with anti-ERp57 or anti-RalBP1 antibodies, as indicated. (D) A whole testis lysate and a GST-RalA pull-down from
testis extract were analysed by Western blot, probed with antibodies recognising ERp57, RalBP1 and PDI. Note that ERp57 was not clearly detected in
the lysate in this experiment, due to the weak ERp57 antibody. Detection in pull-down assays was attributed to enrichment of ERp57 in these
samples. In our subsequent work, we generated and used a stronger ERp57 antibody, which detects ERp57 in tissue extract (e.g., Fig. 3A).
doi:10.1371/journal.pone.0050879.g001
ERp57-RalA Interaction
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30 ml SDS sample buffer was then added, to elute bound proteins,
which were subsequently analysed by SDS-PAGE and Western
blotting.
Results
Identification of ERp57 as a RalA Binding Protein
To identify RalA binding proteins, we used a recombinant
GST-RalA fusion protein coupled to glutathione (GSH) agarose
in affinity chromatography (‘‘pull-down’’) experiments with
various Triton X-100 solubilised rat tissue extracts. GST-RalA
was loaded with either GTP or GDP immediately prior to use.
With this approach we observed a ,58 kDa protein that bound
to GST-RalA in a GDP-dependent manner, which we initially
referred to as p58 (Figure 1A). The amount of p58 that bound
to RalA-GDP was greatest with rat testis extract, followed by
lung, kidney, liver, brain and synaptosome extracts (Figure 1A).
The p58 band from brain extracts was excised from the gel,
and identified by matrix-assisted laser desorption ionisation
time-of-flight mass spectrometry (MALDI-TOF MS, Figure 1B).
The MALDI-TOF MS peptide mass data matched the
hypothetical tryptic fragments of ERp57 (Genebank,
gi|1352384) with a statistical probability of .99%. This
identification was confirmed by MALDI-TOF MS post-source
decay analysis of a peptide of m/z =1188.59 Da, which yielded
a sequence of FV[Met-Ox]QEEFSR. This tryptic peptide
corresponds to amino acids 335–343 of ERp57. We also
identified the testis-derived p58 that bound to RalA, by both
MALDI-TOF MS (data not shown) and Edman sequencing of
four tryptic peptides. The peptides sequenced precisely matched
the sequence of ERp57 at residues 141–152 (TEDEFKK-
FISDK), 259–270 (DLLTAYYDVDYE), 306–317
(TFSHELSDFGLE), and 352–362 (FLQEYFDGNLK). Western
blotting confirmed that ERp57 bound specifically to RalA-GDP
in both synaptosome and testis extracts, while the opposite and
expected GTP-dependent binding was observed for the known
RalA effector protein RalBP1 in a parallel experiment
(Figure 1C).
ERp57 is a member of the Protein Disulfide Isomerise (PDI)
family, which encompasses a highly versatile group of proteins that
have an N-terminal signal sequence and at least one thioredoxin-
like domain [31]. The best characterised member of this family is
its namesake, PDI. PDI is the closest human paralog of ERp57,
with 33% amino acid sequence identity and the same overall
domain layout. Therefore, as a test of the specificity of the ERp57-
RalA interaction, we examined GST-RalA pull-downs from rat
testis extract for the presence of PDI. RalA bound ERp57 and
RalBP1, as expected, but it did not bind PDI (Figure 1D, lanes 2
and 3), despite PDI’s presence in the lysate (lane 1). It is concluded
that the binding of recombinant RalA-GDP by ERp57 in tissue
extracts is specific, and is not a property of all PDIs.
The ERp57-RalA Interaction is Direct and Redox-sensitive
We next tested whether the interaction between RalA and
ERp57 was direct, or if it required the presence of some other
factor from tissue lysates. A 6x-His tagged ERp57, lacking the N-
terminal 23-amino-acid signal sequence (Figure 2A), was expressed
and purified from E. coli, and then used in pull-down experiments
with GST-RalA. Like tissue-derived ERp57, purified wild-type
6xHis-ERp57 bound RalA in a GDP-dependent manner (Fig-
ure 2B, lanes 1 and 2), demonstrating that their interaction is
direct.
ERp57 has four thioredoxin-like domains, denoted (from the
N- to the C-terminus) a, b, b’ and a’ (Figure 2A). The a and a’
domains possess typical thioredoxin-like active site motifs
(CGHC) that mediate disulfide exchange in specific substrate
proteins, involving the two Cys residues. The b and b’ domains
lack this motif, but they retain the thioredoxin fold and are
involved in substrate binding [32]. During its function as
a protein disulfide isomerise, ERp57 forms an intermediate
intermolecular disulfide bond with a substrate protein [33].
Although RalA does not contain any disulfide bonds that would
require PDI activity for formation [34], we tested whether the
ERp57-RalA interaction involved disulfide bonding. A GST-
RalA pull-down experiment with purified 6xHis-ERp57 was
analysed by non-reducing SDS-PAGE and Western blotting
using antibodies recognising the 6xHis tag. No band was
detected at a molecular weight of ,100 kDa (the combined
mass of 6xHis-ERp57 and GST-RalA) or greater (Figure 2B,
lanes 3 and 4), suggesting that the ERp57-RalA interaction does
not involve disulfide bonding between the two proteins.
ERp57 is a redox-sensitive protein, and cellular oxidative stress
elicited with hydrogen peroxide induces oxidation of its active site
thiols and S-glutathionylation [35,36]. The oxidised state of
ERp57 is required for its ability to bind DNA via the a’ domain
[37]. Similarly, we found that the binding of 6xHis-ERp57 to
GST-RalA was strongly inhibited by the addition of the reducing
agent dithiothreitol (DTT) (Figure 2C, top panel), suggesting that
the oxidised form of ERp57 is required for strongest binding to
RalA. Using this principle, we have developed a method for rapid
purification of native ERp57 from rat testis lysate, by elution of
bound ERp57 from GST-RalA-GDP affinity beads using DTT
(data not shown).
To investigate the role of the a and a’ thiol-containing
domains of ERp57 in redox-state-dependent binding to RalA,
we mutated the pair of active-site Cys residues in either one or
both of the a and a’ domains to a pair of Ser residues
(Figure 2A). The binding to RalA was similar for 6xHis-ERp57
("wt ERp57") and all three mutant proteins (Figure 2C, lane 1).
Therefore, the cysteine residues are not essential for binding,
despite the redox-state-dependence of the ERp57-RalA in-
teraction. DTT-mediated inhibition of ERp57 binding to RalA
was not greatly affected by individual mutation of either the a or
the a’ domain (Figure 2C, middle panels). However, the double
domain mutant (a+a’), abolished the redox-sensitivity of the
ERp57-RalA interaction (Figure 2C, lower panel). The above
findings suggest that the conformation of ERp57 required to
bind to RalA tightly is acquired in ERp57’s oxidised state, and
this conformation is somehow mimicked by mutation of the
pairs of active-site Cys residues to Ser. Since all four cysteine
mutations are required to abolish DTT sensitivity, it would
appear that the a and a’ domains cooperate in some manner in
binding to RalA.
To determine if the effect of reducing agents is specific to the
ERp57-RalA interaction, we investigated their effect on the GTP-
dependent binding of RalA to its effectors. A GST-RalA pull-
down experiment using rat testis lysate was performed in the
presence of various redox reagents and the RalA-interacting
proteins were detected by Western blotting. Both DTT and the
physiological reducing agent GSH inhibited the ERp57-RalA
interaction, whereas the oxidised form of glutathione (GSSG) had
no effect (Figure 2D). GTP-dependent binding to both RalBP1
and the exocyst complex (Sec6 antibody) were slightly elevated in
the presence of either DTT or GSH, but were unaffected by
GSSG (Figure 2D). This is probably due to a greater availability of
RalA due to the absence of bound ERp57, but it is clear that no
large changes in binding patterns were evident for RalBP1 and
exocyst under the various redox conditions.
ERp57-RalA Interaction
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The ERp57-RalA Interaction Involves the Switch II Region
of RalA
Nucleotide-dependent conformational changes in RalA are
essentially confined to two regions, switch I and switch II, that
regulate interactions with RalA effectors [34,38]. Switch II is
frequently the primary binding site for the GDP-dependent
binding of proteins to other small GTPases [5,39,40]. We
therefore designed point mutations in RalA’s switch II region
with the aim of identifying important amino-acid residues in RalA
for ERp57 binding. The mutations D74A, Y75A, A77R and I78N
were selected based on a modelled structure of RalA and
a knowledge of previous mutations affecting the GDP-dependent
interactions of other small GTPases [5,41,42]. The mutation
D49A (from switch I) in RalA was included as a control that was
previously reported to selectively lose interaction with RalBP1 and
not the exocyst [18,43].
Purified GST-RalA and the various mutants were loaded with
either GDP or GTP for use in pull-down experiments using rat
testis extract. Interestingly, the RalA.D49A mutant efficiently
bound ERp57, but the nucleotide dependence of ERp57 binding
was completely lost (Figure 3A). Nucleotide-dependent binding by
the exocyst (Sec6 antibody) was observed in the same sample
(Figure 3A), whereas RalBP1 failed to bind both the GDP- and
GTP-bound form of RalA.D49A, as expected [18,43]. The
behaviour of RalA.D49A strongly suggests that the regions of
RalA that normally interact with ERp57 and RalBP1 are trapped
in the GDP-bound conformation in this mutant, even in the
presence of GTP. These findings confirm that some of the normal
nucleotide-dependent conformational changes do not occur in
RalA.D49A. Thus, the D49 residue is critical in transmitting the
chemical information of the nucleotide to RalA’s structure and
binding-partners. It is also clear that mutations of D49 would be
expected to affect more than one Ral regulatory pathway.
The mutations in RalA’s switch II region (D74A, Y75A, A77R
and I78N) greatly diminished binding to ERp57 (Figure 3A).
Essentially complete loss of ERp57 binding was observed for I78N.
In contrast, RalBP1 and the exocyst (Sec6) exhibited apparently
normal GTP-dependent binding to all four switch II mutants
(Figure 3A). We conclude that specific RalA-ERp57 binding
involves the switch II region of RalA, and that switch I controls
nucleotide-dependence of the RalA-ERp57 interaction.
ERp57 Inhibits GDP Dissociation from RalA in a Redox-
sensitive Manner
To determine if ERp57 is a regulator of Ral activity, we
performed standard in vitro assays for GEF, GAP and GDI
activities. We did not detect GEF or GAP activity of recombinant
ERp57 (data not shown). However, GDI assays, based on
Figure 2. The ERp57-RalA interaction is direct and is redox-regulated. (A) The domain organisation of ERp57, showing the active cysteine
thiol groups in their oxidised state (indicated by SS). The ERp57 catalytic site point mutations used are indicated. ERp57 also has a signal sequence at
the N-terminus, and a nuclear localisation sequence (KPKKKKK) followed by an ER retrieval sequence (QEDL) at the C-terminus. (B) Purified 6xHis-
ERp57 was used in GST-RalA pull-down experiments and was analysed by both reducing and non-reducing SDS-PAGE followed by Western blotting
with an anti-6xHis-tag antibody. (C) 6xHis-ERp57 and mutants were purified and bound to GST-RalA loaded with GTP or GDP in the presence or
absence of 1 mM DTT. The relative input levels of ERp57 or mutant proteins were analysed by Coommassie stained SDS polyacrylamide gels (lane 5).
Results are representative of at least two independent experiments. (D) GST-RalA pull-down experiments using rat testis lysate in the presence of the
indicated redox reagents were analysed by SDS-PAGE and Western blotting to detect ERp57, RalBP1 and Sec6.
doi:10.1371/journal.pone.0050879.g002
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monitoring the dissociation of radio-labelled GDP from RalA,
revealed a redox-sensitive GDI activity of ERp57. Under control
conditions (no ERp57), 21% of the initial RalA-bound 3H-GDP
remained after 1 hour (Figure 4A). However, in the presence of
6xHis-ERp57, 63% of the original protein-bound 3H-GDP was
retained after one hour (Figure 4A). We conclude that 6xHis-
ERp57 inhibits the dissociation of GDP from RalA in vitro. We
refer to this as RalGDI activity, however it is noteworthy that the
usual definition of a GDI also includes a membrane removal
activity (addressed further below).
Next, we examined the concentration dependence of the
RalGDI activity of ERp57 in the presence and absence of DTT.
The RalGDI activity of 6xHis-ERp57 was concentration de-
pendent (Figure 4B, filled symbols). DTT inhibited RalGDI
activity at all concentrations of 6xHis-ERp57, but the relative
decrease was greatest at higher 6xHis-ERp57 concentrations
(Figure 4B, open symbols). These data suggest that reduced
ERp57 is a weak RalGDI compared to oxidised ERp57, consistent
with the binding patterns described above.
To establish which of ERp57’s pairs of catalytic Cys residues
might be responsible for the redox-sensitivity of RalGDI activity,
the mutant ERp57 proteins (Figure 2A) were used in RalGDI
assays. Both 6xHis-ERp57 and the a domain mutant inhibited
GDP dissociation to a similar extent (Figure 4C). The GDI activity
of the a’ and the a+a’ domain mutants were greater, suggesting that
they might have a slightly higher affinity than wild-type ERp57.
DTT had the effect of increasing GDP dissociation from RalA in
all cases (Figure 4C), but the percent increase differed between the
four proteins, as seen in the data summary shown in Figure 4D.
Mutation of either the a or the a’ domain Cys residues partly
abolished the DTT-sensitivity of the GDI activity, compared to
wild-type ERp57, but the affect of DTT on the a+a’ domain
mutant was relatively minor. It therefore appears that the oxidised
state of the pairs of Cys residues in either domain individually
contributes to RalGDI activity. This is consistent with the
mutation binding studies (Figure 2C), where the a+a’ domain
mutant ERp57 was insensitive to the action of DTT to inhibit the
ERp57-RalA interaction. These results suggest a hypothesis
whereby oxidised ERp57 in a cellular context would display
maximal RalGDI activity.
Oxidative Treatment Inhibits Cellular RalA Activity via
ERp57
Since oxidation of ERp57’s catalytic Cys residues is associated
with maximal RalGDI activity in vitro (Figure 4), and ERp57 can
be oxidised in cells following oxidative stress [35], the next series of
experiments were designed to determine whether RalA activity is
redox-sensitive in cells, and whether ERp57 is involved. We
investigated RalA activity in A431 cells treated with hydrogen
peroxide (H2O2), since A431 cells have characterised redox-
signalling processes [44,45]. We used an assay for measuring Ral
activity that utilises the GST-tagged Ral binding domain (GST-
RalBD) of RalBP1 to selectively isolate and measure the level of
GTP-bound active RalA from cell lysates [46].
Recombinant GST-RalBD was coupled to GSH-agarose and
used in pull-down experiments followed by Western blotting using
an anti-RalA antibody. H2O2 treatment of serum-starved A431
cells decreased the basal level of RalA activity in a time and
concentration dependent manner (Figures 5A, 5B). An inhibition
of 50% of RalA activity was obtained by treatment of the cells with
1 mM H2O2 and maximal inhibition was reached after 30
minutes. Protection from oxidative stress can be achieved by the
use of the cell-permeable antioxidant N-acetylcysteine (NAC) [44].
A431 cells appeared normal after overnight pre-treatment with
30 mM NAC, and this treatment did not significantly influence
the basal level of RalA activation (Figure 5C, lanes 1 and 2).
However, it abolished H2O2-induced RalA inactivation (lanes 3
and 4). None of the treatments altered the total level of cellular
RalA (Figure 5C, lower panel).
To address whether the H2O2-induced RalA inhibition is
mediated by ERp57, ERp57 (N-terminally GFP-tagged) was
expressed in A431 cells that were then serum-starved and treated
with 1 mMH2O2 for 30 minutes. In cells transfected with the GFP
vector (pDEST53) alone, H2O2 decreased RalA activity as we saw
previously (Figure 5D, upper panel, lanes 1 and 2). Transfection
with GFP-ERp57 had no effect on basal RalA activity, but
treatment of these cells with H2O2 elicited a much greater
decrease in RalA activity than the GFP vector alone (compare
lanes 2 and 4, Figure 5D). No change was observed in the total
cellular level of RalA. Given that the transfection efficiency was
routinely around 20–30% (data not shown), the expression of
GFP-ERp57 greatly sensitised the transfected cells to the effect of
H2O2 on RalA activity, but has little effect on RalA activity in the
absence of the oxidative treatment. The results suggest that ERp57
participates in cellular inactivation of RalA in response to H2O2.
Figure 3. ERp57-RalA interaction involves the switch II region
of RalA. (A) GST-RalA or the indicated mutants were loaded with GDP
or GTP and then used as bait for pull-down experiments using rat testis
lysate (RTL). Bound proteins were analysed Western blot using anti-
ERp57, anti-RalBP1, or anti-Sec6 antibodies. The experiment shows
three blots from the same pull-down experiment and results are
representative of at least three independent experiments for each
construct. (B) Crystal structure of GDP-bound RalA [55], indicating the
switch I (cyan) and switch II (red) regions and the residues mutated for
pull-down assays. (Pdb code: 1U90).
doi:10.1371/journal.pone.0050879.g003
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Oxidative Treatment Affects the Subcellular Distribution
of RalA
GDI proteins usually regulate the subcellular localisation of
their target small GTPases by moving them from the membrane
surface into the cytosol. This sequesters and maintains the
inactive form of the small GTPase [7,12]. ERp57 has a well-
defined function in the maturation of certain glycoproteins in
the endoplasmic reticulum (ER) and in redox-regulated in-
teraction with tapasin during antigen presentation for the
immune system [47,48]. However, it is now clearly established
that ERp57 has several additional roles in other regions of the
cell, including the cytosol and nucleus [49–51], as well as the
cell surface [52,53].
To begin investigating the cellular localisation of RalA-ERp57
interactions, we tested the effects of oxidative treatment on RalA
sub-cellular distribution. A431 cells were treated with various
redox reagents, subjected to hypotonic lysis and separated into
membrane and S100 cytosol fractions by ultracentrifugation
(Figure 6). The S100 fractions were then analysed by SDS-PAGE
and Western blotting for RalA. The basal level of cytosolic RalA
(Figure 6, lane 1) represented approximately 1% of total cellular
RalA (data not shown). Overnight pre-treatment of the cells with
NAC reduced the level of cytosolic RalA to an even lower level
(Figure 6, lane 2). In contrast, treatment of A431 cells with H2O2
led to a significant increase in the relative amount of cytosolic
RalA (,4.5 fold; Figure 6, lanes 1 and 3). NAC blocked the H2O2-
mediated increase of cytosolic RalA (Figure 6, lane 4). The
corresponding membrane fractions were also analysed for RalA,
but no significant changes were observed (data not shown),
reflecting the dominance of the membrane fraction in total RalA
levels. These results indicate that a relatively small fraction of total
cellular RalA is withdrawn from the membranes into the cytosol
Figure 4. ERp57 has redox-sensitive RalGDI activity. (A) Time course of 3H-GDP dissociation from GST-RalA in the presence or absence of
ERp57. 4 mM GST-RalA was pre-loaded with 3H-labelled GDP and incubated with or without 8 mM 6xHis-ERp57. Protein was collected by nitrocellulose
filtration and the amount of bound 3H-GDP was determined by scintillation counting. Error bars represent SEM (n= 3). (B) GDI activity assays were
performed as in (A) at the 30 minute reaction time, with and without the presence of 1 mM DTT at various ERp57 concentrations. Error bars represent
SEM (n= 3). (C) GDI activity of 6xHis-ERp57 and mutants. GDI activity was determined with a 30 minute incubation time. Error bars represent SEM
(n=3), * represents p,0.05 and ** ,0.01 using a two-tailed t-test relative to the no DTT sample in each case. (D) Percent decrease in GDI activity in
the presence of DTT relative to the no-DTT experiment for each ERp57 variant, derived from the measurements in (C).
doi:10.1371/journal.pone.0050879.g004
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through oxidative treatment. This may occur in the case of
a specifically localised signalling process.
Discussion
We have discovered that ERp57 specifically interacts with the
GDP-bound form of the small GTPase RalA. Despite its
established role in the endoplasmic reticulum, ERp57 plays
numerous signalling and other roles outside the endoplasmic
reticulum [49–51], and it is considered most likely that RalA-
ERp57 interactions would also take place outside the ER in vivo.
We showed that ERp57 inhibited dissociation of GDP from RalA.
Both RalA binding and RalA-GDP stabilisation by ERp57 were
redox-sensitive in vitro, and this can be attributed to conforma-
tional changes in ERp57 in response to its redox environment,
because mutation of the ERp57 active site cysteine residues to
serine abolished redox-sensitivity of the ERp57-RalA interaction
without the involvement of inter-molecular disulphide bonding
between RalA and ERp57.
We mapped important residues of the RalA-ERp57 binding site
to the switch II region of the GTPase domain of RalA, which in
other small GTP binding proteins is involved in interactions with
GDP-dependent binding partners such as GDIs [5,41,54]. In
particular, the RalA.I78N mutant failed to bind ERp57 but still
Figure 5. Oxidative stress inhibits cellular RalA activity via ERp57. GST-RalBD Ral activity assays monitoring the level of GTP-bound
endogenous RalA (A) A431 cells were treated with 2 mM H2O2 and then the amount of active RalA-GTP was measured over 45 min. Error bars show
SEM (n= 3). (B) Serum starved A431 cells were treated with various concentrations of H2O2 for 30 minutes and then RalA-GTP was measured (n=3).
(C) RalA activity assays examining the effect of pre-treatment with the antioxidant N-acetylcysteine (NAC) for 18 hours. The intensity of RalA staining
in the upper panel indicates the level of RalA-GTP in a representative experiment, and the quantification of these bands by densitometry is shown
beneath (n= 6). The relative levels of total cellular RalA are shown in the lower panel (from 2% of total protein loaded onto the GST-RalBD column).
(D) Expression of GFP-ERp57 enhances the H2O2-induced inactivation of RalA in A431 cells. In the lower panel, error bars represent SEM (n= 9).
doi:10.1371/journal.pone.0050879.g005
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bound RalBP1 and the exocyst in the expected GTP-dependent
manner. I78 is a specific tree-determinant residue for Ral within
the Ras family [55], which are conserved residues within a given
subfamily that differ from the other subfamilies, suggesting that
ERp57 binding and GDI activity might be confined to the Ral
sub-family.
Interestingly, the C3 exoenzyme from Clostridium botulinum
(C3bot) binds with high specificity and affinity to RalA through
the switch II region of RalA, and this causes a GDI-like effect
similar to that observed here [56]. The structure of the RalA-
GDP-C3bot complex demonstrated the direct involvement of at
least two RalA switch II residues (D74 and Y75) at the protein-
protein interface that were identified in the present study to be
involved in the RalA-ERp57 interaction (Figure 4). This raises the
possibility that the RalA-ERp57 interaction could be a target of
the C3bot toxin.
ERp57 shows similar functionality to known GDI proteins. For
example, RhoGDI interactions with the small GTPases Cdc42
and Rac1 also map to switch II [5,57]. Furthermore, RhoGDIs
require two domains for maximal GDI activity; likewise, ERp57
appears to require both the a and a’ domain active-site cysteines
for normal binding and activity, implying multiple interaction sites
and raising the possibility of a stepwise binding and regulatory
activity. Indeed the data in Figure 4 are consistent with the
possibility that one domain of ERp57 may bind RalA to achieve
the low GDI activity of reduced ERp57, followed by binding of the
second domain in a redox-sensitive manner, to achieve maximal
GDI activity.
ERp57 action on RalA shares the general feature of redox-
sensitivity with RabGDIs. RabGDI-1 and -2 responded to
oxidative treatment of adipocytes by dissociation from mem-
branes, which is a key step in the regulatory activity of GDIs [58].
Conversely, antioxidant treatments lead to membrane retention of
RabGDI, and the arrest of normal vesicle trafficking events within
the cell [58]. Despite these functional parallels, ERp57 bears no
clear homology with any of the known GDI proteins, and no
homology exists between RabGDIs and RhoGDIs either [5,57],
highlighting the diversity seen in GDIs.
Recently, it was shown that a GDI-like activity of PDEd is an
important contributor to Ras sub-cellular distribution between
membranes and cytosol; PDEd expression increased Ras plasma
membrane localisation, activity, and diffusion through the cytosol
[59]. The ERp57-RalA system would appear to differ, as we found
that ERp57 expression decreased the activity of RalA under
oxidative conditions that also increased the levels of cytosolic RalA
(Figures 5 and 6). Molecular characterisation of the ERp57-RalA
interaction (Figures 2 and 3) also showed that there are significant
differences in the binding specificity and mechanism between these
systems [11].
Our investigation of endogenous cellular RalA found that it was
sensitive to the effects of redox agents, in both its signalling activity
and subcellular localisation (Figures 5 and 6). The regulation of
cell function by redox-dependent signalling pathways has been
well documented [60]. Ligand stimulation of many types of
receptors results in the production of various reactive oxygen
species (ROS) as intracellular second messenger species [61]. The
production of ROS (such as H2O2) is constrained spatially, rather
than influencing the overall redox state of the cell [60]. The
experimental use of redox agents in cell culture broadly affects
redox signalling pathways that physiologically only occur in
distinct subcellular compartments or redox micro-environments
[45]. Our experiments involving cellular oxidative treatment
(H2O2) showed that supplementary expression of ERp57 signifi-
cantly exacerbated the inactivation of RalA observed in response
to H2O2. Therefore, our data support the notion that a localized
oxidative signalling process oxidises ERp57 to result in a strong
RalA-ERp57 interaction and GDI activity.
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Figure 6. Redox reagents alter the subcellular distribution of
RalA. A431 cells were treated with 5 mM H2O2 for 30 minutes, 20 mM
NAC for 18 hours, or sequential treatment with 20 mM NAC for 18
hours and then 5 mM H2O2 for 30 minutes. Cell lysates were then
fractionated by ultracentrifugation. The cytosolic fraction (S100) was
analysed by Western blotting for the presence of endogenous RalA
(upper panel), and quantitated by densitometry (central panel). Error
bars represent the SEM (n= 3). The lower panel shows total cell protein
stain of each of the samples represented in the upper panel.
doi:10.1371/journal.pone.0050879.g006
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